These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26322048)

  • 1. Complement in the Homeostatic and Ischemic Brain.
    Alawieh A; Elvington A; Tomlinson S
    Front Immunol; 2015; 6():417. PubMed ID: 26322048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement.
    Alawieh A; Elvington A; Zhu H; Yu J; Kindy MS; Atkinson C; Tomlinson S
    J Neuroinflammation; 2015 Dec; 12():247. PubMed ID: 26714866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Complement System in Ischemic Stroke: A Comprehensive Review.
    Ma Y; Liu Y; Zhang Z; Yang GY
    Aging Dis; 2019 Apr; 10(2):429-462. PubMed ID: 31011487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injury site-specific targeting of complement inhibitors for treating stroke.
    Alawieh A; Tomlinson S
    Immunol Rev; 2016 Nov; 274(1):270-280. PubMed ID: 27782326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
    Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
    Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
    Brennan FH; Lee JD; Ruitenberg MJ; Woodruff TM
    Semin Immunol; 2016 Jun; 28(3):292-308. PubMed ID: 27049459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
    J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement component C3 mediates inflammatory injury following focal cerebral ischemia.
    Mocco J; Mack WJ; Ducruet AF; Sosunov SA; Sughrue ME; Hassid BG; Nair MN; Laufer I; Komotar RJ; Claire M; Holland H; Pinsky DJ; Connolly ES
    Circ Res; 2006 Jul; 99(2):209-17. PubMed ID: 16778128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation and inhibition in myocardial ischemia and reperfusion injury.
    Homeister JW; Lucchesi BR
    Annu Rev Pharmacol Toxicol; 1994; 34():17-40. PubMed ID: 8042849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement, neutrophils and free radicals: mediators of reperfusion injury.
    Lucchesi BR
    Arzneimittelforschung; 1994 Mar; 44(3A):420-32. PubMed ID: 8185717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb remote ischemic per-conditioning in combination with post-conditioning reduces brain damage and promotes neuroglobin expression in the rat brain after ischemic stroke.
    Ren C; Wang P; Wang B; Li N; Li W; Zhang C; Jin K; Ji X
    Restor Neurol Neurosci; 2015; 33(3):369-79. PubMed ID: 25868435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative neuroproteomics of an in vivo rodent model of focal cerebral ischemia/reperfusion injury reveals a temporal regulation of novel pathophysiological molecular markers.
    Datta A; Jingru Q; Khor TH; Teo MT; Heese K; Sze SK
    J Proteome Res; 2011 Nov; 10(11):5199-213. PubMed ID: 21950801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARĪ³ upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats.
    Jiang Y; Li L; Liu B; Zhang Y; Chen Q; Li C
    Med Sci Monit; 2015 Jan; 21():268-75. PubMed ID: 25619160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function.
    Enzmann G; Kargaran S; Engelhardt B
    Ther Adv Neurol Disord; 2018; 11():1756286418794184. PubMed ID: 30181779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species.
    Liu H; Wei X; Kong L; Liu X; Cheng L; Yan S; Zhang X; Chen L
    Int J Biol Sci; 2015; 11(5):525-35. PubMed ID: 25892960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervention strategies for neonatal hypoxic-ischemic cerebral injury.
    Perlman JM
    Clin Ther; 2006 Sep; 28(9):1353-65. PubMed ID: 17062309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver.
    Zwacka RM; Zhang Y; Halldorson J; Schlossberg H; Dudus L; Engelhardt JF
    J Clin Invest; 1997 Jul; 100(2):279-89. PubMed ID: 9218504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.